Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 3,222 | 19,552 | 21,762 | 40,795 | 890 |
| Cost of Goods | 532 | 10,068 | 11,134 | 21,054 | 2,695 |
| Gross Profit | 2,690 | 9,484 | 10,628 | 19,741 | -1,805 |
| Operating Expenses | 21,866 | 42,490 | 36,459 | 52,765 | 9,233 |
| Operating Income | -18,644 | -32,938 | -25,697 | -32,970 | -10,343 |
| Interest Expense | 5 | 10 | 9 | 2 | 572 |
| Other Income | -687 | 48 | 7,424 | 6,788 | -247 |
| Pre-tax Income | -19,336 | -32,900 | -18,282 | -26,184 | -11,162 |
| Income Tax | -35,900 | -1,216 | -609 | -151 | 257 |
| Net Income Continuous | 16,564 | -31,684 | -17,673 | -26,033 | -11,419 |
| Net Income Discontinuous | 2,719 | -3,003 | -15,786 | N/A | -22,653 |
| Net Income | $19,283 | $-34,687 | $-33,459 | $-26,033 | $-34,072 |
| EPS Basic Total Ops | 0.05 | -0.09 | -0.09 | -0.07 | -0.06 |
| EPS Basic Continuous Ops | 0.05 | -0.08 | -0.05 | -0.07 | -0.15 |
| EPS Basic Discontinuous Ops | 0.01 | -0.01 | -0.04 | N/A | -0.08 |
| EPS Diluted Total Ops | 0.05 | -0.09 | -0.09 | -0.07 | -0.06 |
| EPS Diluted Continuous Ops | 0.05 | -0.08 | -0.05 | -0.07 | -0.15 |
| EPS Diluted Discontinuous Ops | 0.01 | -0.01 | -0.04 | N/A | -0.08 |
| EPS Diluted Before Non-Recurring Items | 0.05 | -0.06 | -0.05 | -0.06 | -0.07 |
| EBITDA(a) | $-17,815 | $-32,028 | $-22,433 | $-29,640 | $-7,522 |